시장보고서
상품코드
1098611

국소 코르티코스테로이드 시장 규모, 점유율, 전망, 기회(2022-2030년) : 제제, 용도, 유통 채널, 지역별

Topical Corticosteroids Market, by Formulation, by Application, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

발행일: | 리서치사: Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

참여 사업자는 제네릭 제품 발매에 주력하고 있어, 예측기간 중 세계의 국소 코르티코스테로이드(스테로이드) 시장 성장에 기여할 것으로 예측됩니다. 또한 기업에 의한 인수 등의 전략, 습진의 더 나은 치료를 위한 이니셔티브 증가 등도 예측기간 중 시장 성장을 지지할 것으로 예상됩니다.

세계의 국소 코르티코스테로이드(Topical Corticosteroids) 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 대한 각종 영향요인 분석, 규제·상환 환경, 시장 규모 추정과 예측, 각종 부문·지역/주요 국가별 내역, 경쟁 환경, 주요 기업 개요 등을 정리했습니다.

목차

제1장 조사 목적과 가정

제2장 시장 개요

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
  • 영향 분석
  • Porter's Five Forces 분석
  • 산업 동향
  • 주요 하이라이트
  • 역학
  • 상환 시나리오
  • 규제 시나리오
  • 제품 발매·승인
  • 인수·제휴 시나리오

제4장 세계의 국소 코르티코스테로이드(스테로이드) 시장 : COVID-19의 영향

  • COVID-19 : 역학
  • 국소 코르티코스테로이드 수요와 공급에 대한 COVID-19의 영향
  • 헬스케어 부문 전체에 대한 COVID-19의 영향

제5장 세계의 국소 코르티코스테로이드(스테로이드) 시장 : 제제별

  • 크림
  • 연고
  • 기타

제6장 세계의 국소 코르티코스테로이드(스테로이드) 시장 : 용도별

  • 여드름
  • 피부염
  • 건선
  • 습진
  • 과다색소침착
  • 기타

제7장 세계의 국소 코르티코스테로이드(스테로이드) 시장 : 유통 채널별

  • 병원 약국
  • 소매 약국
  • 온라인 약국

제8장 세계의 국소 코르티코스테로이드(스테로이드) 시장 : 지역별

  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동
  • 아프리카

제9장 경쟁 상황

  • 기업 개요
    • GlaxoSmithKline plc
    • Merck &Co., Inc.
    • Sandoz International GmbH
    • AstraZeneca
    • LEO Pharma
    • Cipla Inc.
    • Bristol-Myers Squibb Company
    • Almirall, SA
    • Bausch Health
    • Sanofi SA

제10장 섹션

KSM 22.07.15

Topical steroids are available in a variety of strengths and are classified into seven classes based on their potency. Class I (class one) contains the strongest steroids, while Class VII contains the weakest (class seven).

Topical steroids in Class I are 600 to 1,000 times more powerful than those in Class VII. The right steroid strength, or potency, is determined by a number of factors.

Babies, for example, absorb topical steroids much faster than adults, so a low-potency steroid may be required.

Topical steroids are absorbed quickly in parts of the body where skin touches flesh, such as the armpits or beneath the breasts, or in sensitive areas of skin, such as the eyelids, and may only require a low-potency formulation.

Market Dynamics

Market players are focused on launching generic products, this is expected to contribute to growth of the global topical corticosteroids (steroids) market over the forecast period. For instance, in March 2019, Lupin Limited, an Indian pharmaceutical company announced the launch of Fluocinonide Ointment USP, 0.05 %, which was approved by the US Food and Drug Administration (FDA) in July 2018. Lupin's Fluocinonide Ointment USP, 0.05% is the generic equivalent of County Line Pharmaceuticals LLC's Lidex Ointment 0.05%. It is used to treat inflammatory and pruritic symptoms associated with corticosteroid-responsive dermatoses.

Market players are involved in strategies such as acquisitions, which is expected to contribute to growth of global topical corticosteroids (steroids) market. For instance, in October 2018, Mayne Pharma, a specialty pharmaceutical company, announced that it has acquired the US and Australia rights to halobetasol foam 0.05% for US$32.0 million. Halobetasol foam is a highly potent corticosteroid that is used to treat plaque psoriasis.

Increasing initiatives by non-profit organizations for better treatment of eczema is expected to aid growth of the global topical corticosteroids (steroids) market over the forecast period. For instance, in September 2021, on world eczema day (September 14), eleven patient organizations from eight countries came together to launch the Global Patient Initiative to Improve Eczema Care (GPIIEC). The programme is a global effort to develop a uniform "yardstick" for evaluating how well health systems respond to demands of patients and their caregivers. This groundbreaking collaboration has discovered aspects of health-care delivery that matter most to patients and caregivers, as well as indicators to assess them across eight developed countries (Australia, Canada, Denmark, France, Italy, Germany, United States, and the United Kingdom).

Key features of the study:

  • This report provides an in-depth analysis of global topical corticosteroids (steroids) market , provides market size (US$ Billion), and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global topical corticosteroids (steroids) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include GlaxoSmithKline plc, Merck & Co., Inc., Sandoz International GmbH, AstraZeneca, LEO Pharma, Cipla Inc., Bristol-Myers Squibb Company, Almirall, S.A., Bausch Health, and Sanofi SA
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global topical corticosteroids (steroids) market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global topical corticosteroids (steroids) market.

Detailed Segmentation:

  • Global Topical Corticosteroids (steroids) Market , By Formulation:
    • Creams
    • Ointments
    • Gels
    • Others (solutions, foams, spray, etc.)
  • Global Topical Corticosteroids (steroids) Market , By Application:
    • Acne
    • Dermatitis
    • Psoriasis
    • Eczema
    • Hyperpigmentation
    • Others (rash, etc.)
  • Global Topical Corticosteroids (steroids) Market , By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Topical Corticosteroids (steroids) Market , By Region:
    • North America
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Country:
      • U.K.
      • Germany
      • Italy
      • Spain
      • France
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • GlaxoSmithKline plc*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Merck & Co., Inc.
    • Sandoz International GmbH
    • AstraZeneca
    • LEO Pharma
    • Cipla Inc.
    • Bristol-Myers Squibb Company
    • Almirall, S.A.
    • Bausch Health
    • Sanofi SA

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Formulation
    • Market Snippet, By Application
    • Market Snippet, By Distribution channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Porter's Analysis
  • Industry Trends
  • Key Highlights
  • Epidemiology
  • Reimbursement Scenario
  • Regulatory Scenario
  • Product Launch and Approvals
  • Acquisition and Collaboration Scenario

4. Global Topical Corticosteroids (steroids) Market - Impact of Coronavirus (Covid-19) Pandemic

  • COVID-19 Epidemiology
  • Impact of COVID-19 on Demand and Supply of Topical Corticosteroids
  • Impact of COVID-19 on the overall Healthcare Sector

5. Global Topical Corticosteroids (steroids) Market , By Formulation, 2017-2030 (US$ Billion)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Creams
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Ointments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Gels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)

6. Global Topical Corticosteroids (steroids) Market , By Application, 2017-2030 (US$ Billion)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Acne
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Dermatitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Psoriasis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Eczema
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Hyperpigmentation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)

7. Global Topical Corticosteroids (steroids) Market , By Distribution Channel, 2017-2030 (US$ Billion)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)

8. Global Topical Corticosteroids (steroids) Market , By Region, 2017-2030 (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2030
    • Regional Trends
  • North America
    • Market Size and Forecast, By Formulation, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Country, 2017-2030 (US$ Bn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Formulation, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Country, 2017-2030 (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Formulation, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Country, 2017-2030 (US$ Bn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Formulation, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Country, 2017-2030 (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Formulation, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Country/Region, 2017-2030 (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Formulation, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Country/Region, 2017-2030 (US$ Bn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Company Profiles
    • GlaxoSmithKline plc*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Merck & Co., Inc.
    • Sandoz International GmbH
    • AstraZeneca
    • LEO Pharma
    • Cipla Inc.
    • Bristol-Myers Squibb Company
    • Almirall, S.A.
    • Bausch Health
    • Sanofi SA

Key pointers provided are also applicable to other companies covered in the scope of the report.

10. Section

  • Research Methodology
  • About us
  • Contact
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제